TALAMONTI, MARINA
TALAMONTI, MARINA
Dipartimento di Medicina dei sistemi
A clinical case of severe disease burden: an erythrodermic psoriatic patient treated with secukinumab
2018-01-01 Galluzzo, M; D'Adamio, S; Campione, E; Mazzilli, S; Bianchi, L; Talamonti, M
A life with atopic dermatitis: the patient's point of view after a new hope with dupilumab
2020-01-01 D'Adamio, S; Massaro, A; Biocca, S; Bianchi, L; Talamonti, M; Galluzzo, M
A phase II study of ponesimod in chronic plaque psoriasis: improvements in patient-reported outcomes
2013-01-01 Kemeny, L; Yankova, R; Talamonti, M; Vaclavkova, A; Burcklen, M; Thomas, G; D'Ambrosio, D
A phase II study of ponesimod in chronic plaque psoriasis: improvements in patient-reported outcomes Abstracts of the 4th Congress of the Psoriasis International Network. July 4-6, 2013. Paris, France
2013-07-01 Kemeny, L; Yankova, R; Talamonti, M; Vaclavkova, A; Burcklen, M; Thomas, G; D’Ambrosio, D
A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study
2021-01-01 Zagni, E; Bianchi, L; Fabbrocini, G; Corrao, S; Offidani, A; Stingeni, L; Costanzo, A; Pellacani, G; Peris, K; Bardazzi, F; Argenziano, G; Ruffolo, S; Dapavo, P; Carrera, C; Fargnoli, Mc; Parodi, A; Romanelli, M; Malagoli, P; Talamonti, M; Megna, M; Raspanti, M; Paolinelli, M; Hansel, K; Narcisi, A; Conti, A; De Simone, C; Chessa, Ma; De Rosa, A; Provenzano, E; Ortoncelli, M; Moltrasio, C; Fidanza, R; Burlando, M; Tonini, A; Gaiani, Fm; Simoni, L; Zullo, A; Fiocchi, M; Colombo, D
A safety evaluation of guselkumab for the treatment of psoriasis
2018-01-01 Galluzzo, M; D'Adamio, S; Campione, E; Bianchi, L; Talamonti, M
Adalimumab for moderate to severe psoriasis: an open-label, retrospective 3-year study
2008-01-01 Papoutsaki, M; Chimenti, Ms; Talamonti, M; Zangrilli, A; Teoli, M; Kroegler, B; Perricone, R; Chimenti, S
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics
2007-01-01 Papoutsaki, M; Chimenti, Ms; Costanzo, A; Talamonti, M; Zangrilli, A; Giunta, A; Bianchi, L; Chimenti, S
Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients.
2017-04-01 Talamonti, M; Galluzzo, M; Servoli, S; D'Adamio, S; Bianchi, L
Allelic Variants of HLA-C Upstream Region, PSORS1C3, MICA, TNFA and Genes Involved in Epidermal Homeostasis and Barrier Function Influence the Clinical Response to Anti-IL-12/IL-23 Treatment of Patients with Psoriasis
2022-11-21 Morelli, M; Galluzzo, M; Scarponi, C; Madonna, S; Scaglione, Gl; Girolomoni, G; Talamonti, M; Bianchi, L; Albanesi, C
Assessment of HLA Cw6 genotype and correlation to ustekinumab response in a large cohort of patients with moderate-to-severe psoriasis
2016-01-01 Talamonti, M; Galluzzo, M; Chimenti, S; Costanzo, A
Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis
2017-01-01 Galluzzo, M; Talamonti, M; Perino, F; Servoli, S; Giordano, D; Chimenti, S; De Simone, C; Peris, K
Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature
2019-04-10 Galluzzo, M; D'Adamio, S; Teoli, M; Bianchi, L; Talamonti, M
Brodalumab for the treatment of psoriasis
2016-01-01 Galluzzo, M; D'Adamio, S; Bianchi, L; Talamonti, M
Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines
2018-01-01 Cozzani, E; Marzano, Av; Caproni, M; Feliciani, C; Calzavara-Pinton, P; Alaibac, M; Antiga, E; Arisi, M; Assalve, D; Atzori, L; Babino, G; Balato, A; Balato, N; Barbagallo, T; Fortina, Ab; Berardesca, E; Berti, E; Borghi, A; Brazzelli, V; Brumana, Mb; Brusati, C; Caccavale, S; Caldarola, G; Campanati, A; Caro, Rdc; Coati, I; Conti, A; Costanzo, A; Dattola, A; De Simone, C; Di Cesare, A; Di Lernia, V; Di Zenzo, Gm; Fania, L; Filosa, G; Filotico, R; Fusano, M; Galluccio, Ag; Ganzetti, G; Gisondi, P; Guarneri, F; Hansel, K; Javor, S; Laplaca, M; Liberati, G; Lora, V; Merlo, G; Nasca, Mr; Nigro, A; Noal, C; Offidani, A; Papini, M; Parodi, A; Patrizi, A; Peserico, A; Piaserico, S; Prignano, F; Quaglino, P; Rossi, M; Satta, R; Schena, D; Sena, P; Simonetti, O; Stan, Tr; Stingeni, L; Talamonti, M; Tavecchio, S; Tognetti, L; Vascellaro, A; Vassallo, C; Venturini, M; Zampetti, A; Zanca, A
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 pandemic: risk analysis from the PSO-BIO-COVID observational study
2021-01-01 Talamonti, M; Galluzzo, M; Chiricozzi, A; Quaglino, P; Fabbrocini, G; Gisondi, P; Marzano, Av; Potenza, C; Conti, A; Parodi, A; Piaserico, S; Bardazzi, F; Argenziano, G; Rongioletti, F; Stingeni, L; Micali, G; Loconsole, F; Rossi, Mt; Bongiorno, Mr; Feliciani, C; Rubegni, P; Amerio, P; Fargnoli, Mc; Pigatto, P; Savoia, P; Nisticò, Sp; Giustini, S; Carugno, A; Cannavo', Sp; Rech, G; Prignano, F; Offidani, A; Lombardo, M; Zalaudek, I; Bianchi, L; Peris, K
Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature
2020-01-01 Caldarola, G; Pirro, F; Di Stefani, A; Talamonti, M; Galluzzo, M; D'Adamio, S; Magnano, M; Bernardini, N; Malagoli, P; Bardazzi, F; Potenza, C; Bianchi, L; Peris, K; De Simone, C
Clinical severity instruments
2005-01-01 Zangrilli, A; Talamonti, M; Saraceno, R; Chimenti, S
Continuous treatment of plaque-type psoriasis with etanercept: An observational long-term experience
2010-01-01 Esposito, M; Giunta, A; Mazzotta, A; Babino, G; Talamonti, M; Chimenti, Ms; Chimenti, S
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis
2012-09-01 Botti, E; Talamonti, M; Spallone, G; Galluzzo, M; Bavetta, M; Teoli, M; Pinetti, V; Costanzo, A
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2018 | A clinical case of severe disease burden: an erythrodermic psoriatic patient treated with secukinumab | Galluzzo, M; D'Adamio, S; Campione, E; Mazzilli, S; Bianchi, L; Talamonti, M | Articolo su rivista | |
| 1-gen-2020 | A life with atopic dermatitis: the patient's point of view after a new hope with dupilumab | D'Adamio, S; Massaro, A; Biocca, S; Bianchi, L; Talamonti, M; Galluzzo, M | Articolo su rivista | |
| 1-gen-2013 | A phase II study of ponesimod in chronic plaque psoriasis: improvements in patient-reported outcomes | Kemeny, L; Yankova, R; Talamonti, M; Vaclavkova, A; Burcklen, M; Thomas, G; D'Ambrosio, D | Intervento a convegno | |
| 1-lug-2013 | A phase II study of ponesimod in chronic plaque psoriasis: improvements in patient-reported outcomes Abstracts of the 4th Congress of the Psoriasis International Network. July 4-6, 2013. Paris, France | Kemeny, L; Yankova, R; Talamonti, M; Vaclavkova, A; Burcklen, M; Thomas, G; D’Ambrosio, D | Intervento a convegno | |
| 1-gen-2021 | A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study | Zagni, E; Bianchi, L; Fabbrocini, G; Corrao, S; Offidani, A; Stingeni, L; Costanzo, A; Pellacani, G; Peris, K; Bardazzi, F; Argenziano, G; Ruffolo, S; Dapavo, P; Carrera, C; Fargnoli, Mc; Parodi, A; Romanelli, M; Malagoli, P; Talamonti, M; Megna, M; Raspanti, M; Paolinelli, M; Hansel, K; Narcisi, A; Conti, A; De Simone, C; Chessa, Ma; De Rosa, A; Provenzano, E; Ortoncelli, M; Moltrasio, C; Fidanza, R; Burlando, M; Tonini, A; Gaiani, Fm; Simoni, L; Zullo, A; Fiocchi, M; Colombo, D | Articolo su rivista | |
| 1-gen-2018 | A safety evaluation of guselkumab for the treatment of psoriasis | Galluzzo, M; D'Adamio, S; Campione, E; Bianchi, L; Talamonti, M | Articolo su rivista | |
| 1-gen-2008 | Adalimumab for moderate to severe psoriasis: an open-label, retrospective 3-year study | Papoutsaki, M; Chimenti, Ms; Talamonti, M; Zangrilli, A; Teoli, M; Kroegler, B; Perricone, R; Chimenti, S | Intervento a convegno | |
| 1-gen-2007 | Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics | Papoutsaki, M; Chimenti, Ms; Costanzo, A; Talamonti, M; Zangrilli, A; Giunta, A; Bianchi, L; Chimenti, S | Articolo su rivista | |
| 1-apr-2017 | Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients. | Talamonti, M; Galluzzo, M; Servoli, S; D'Adamio, S; Bianchi, L | Articolo su rivista | |
| 21-nov-2022 | Allelic Variants of HLA-C Upstream Region, PSORS1C3, MICA, TNFA and Genes Involved in Epidermal Homeostasis and Barrier Function Influence the Clinical Response to Anti-IL-12/IL-23 Treatment of Patients with Psoriasis | Morelli, M; Galluzzo, M; Scarponi, C; Madonna, S; Scaglione, Gl; Girolomoni, G; Talamonti, M; Bianchi, L; Albanesi, C | Articolo su rivista | |
| 1-gen-2016 | Assessment of HLA Cw6 genotype and correlation to ustekinumab response in a large cohort of patients with moderate-to-severe psoriasis | Talamonti, M; Galluzzo, M; Chimenti, S; Costanzo, A | Intervento a convegno | |
| 1-gen-2017 | Bioelectrical impedance analysis to define an excess of body fat: evaluation in patients with psoriasis | Galluzzo, M; Talamonti, M; Perino, F; Servoli, S; Giordano, D; Chimenti, S; De Simone, C; Peris, K | Articolo su rivista | |
| 10-apr-2019 | Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature | Galluzzo, M; D'Adamio, S; Teoli, M; Bianchi, L; Talamonti, M | Articolo su rivista | |
| 1-gen-2016 | Brodalumab for the treatment of psoriasis | Galluzzo, M; D'Adamio, S; Bianchi, L; Talamonti, M | Articolo su rivista | |
| 1-gen-2018 | Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines | Cozzani, E; Marzano, Av; Caproni, M; Feliciani, C; Calzavara-Pinton, P; Alaibac, M; Antiga, E; Arisi, M; Assalve, D; Atzori, L; Babino, G; Balato, A; Balato, N; Barbagallo, T; Fortina, Ab; Berardesca, E; Berti, E; Borghi, A; Brazzelli, V; Brumana, Mb; Brusati, C; Caccavale, S; Caldarola, G; Campanati, A; Caro, Rdc; Coati, I; Conti, A; Costanzo, A; Dattola, A; De Simone, C; Di Cesare, A; Di Lernia, V; Di Zenzo, Gm; Fania, L; Filosa, G; Filotico, R; Fusano, M; Galluccio, Ag; Ganzetti, G; Gisondi, P; Guarneri, F; Hansel, K; Javor, S; Laplaca, M; Liberati, G; Lora, V; Merlo, G; Nasca, Mr; Nigro, A; Noal, C; Offidani, A; Papini, M; Parodi, A; Patrizi, A; Peserico, A; Piaserico, S; Prignano, F; Quaglino, P; Rossi, M; Satta, R; Schena, D; Sena, P; Simonetti, O; Stan, Tr; Stingeni, L; Talamonti, M; Tavecchio, S; Tognetti, L; Vascellaro, A; Vassallo, C; Venturini, M; Zampetti, A; Zanca, A | Articolo su rivista | |
| 1-gen-2021 | Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 pandemic: risk analysis from the PSO-BIO-COVID observational study | Talamonti, M; Galluzzo, M; Chiricozzi, A; Quaglino, P; Fabbrocini, G; Gisondi, P; Marzano, Av; Potenza, C; Conti, A; Parodi, A; Piaserico, S; Bardazzi, F; Argenziano, G; Rongioletti, F; Stingeni, L; Micali, G; Loconsole, F; Rossi, Mt; Bongiorno, Mr; Feliciani, C; Rubegni, P; Amerio, P; Fargnoli, Mc; Pigatto, P; Savoia, P; Nisticò, Sp; Giustini, S; Carugno, A; Cannavo', Sp; Rech, G; Prignano, F; Offidani, A; Lombardo, M; Zalaudek, I; Bianchi, L; Peris, K | Articolo su rivista | |
| 1-gen-2020 | Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature | Caldarola, G; Pirro, F; Di Stefani, A; Talamonti, M; Galluzzo, M; D'Adamio, S; Magnano, M; Bernardini, N; Malagoli, P; Bardazzi, F; Potenza, C; Bianchi, L; Peris, K; De Simone, C | Articolo su rivista | |
| 1-gen-2005 | Clinical severity instruments | Zangrilli, A; Talamonti, M; Saraceno, R; Chimenti, S | Contributo in libro | |
| 1-gen-2010 | Continuous treatment of plaque-type psoriasis with etanercept: An observational long-term experience | Esposito, M; Giunta, A; Mazzotta, A; Babino, G; Talamonti, M; Chimenti, Ms; Chimenti, S | Articolo su rivista | |
| 1-set-2012 | Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis | Botti, E; Talamonti, M; Spallone, G; Galluzzo, M; Bavetta, M; Teoli, M; Pinetti, V; Costanzo, A | Intervento a convegno |